NEXGEL, Inc. (NASDAQ: NXGL) has announced its fourth-quarter and full-year 2024 financial results, highlighting unprecedented ...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, ...

Verisure’s majority owner Hellman & Friedman has lined up more banks for a potential initial public offering of the security ...

For Q1 2025, NEXGEL expects revenue of at least $2.75 million, while projecting at least $13 million in revenue for the full year 2025. The company anticipates achieving positive EBITDA in 2025.

Private equity funds that own German drugmaker Stada Arzneimittel AG have decided to postpone its planned initial public ...

German pharmaceutical company Stada Arzneimittel has delayed its IPO to the third quarter, while in the same country ...

Hellman & Friedman has selected Goldman Sachs and Morgan Stanley to lead the IPO of security firm Verisure, potentially ...

The private equity owners of Stada Arzneimittel AG have decided to push back the German drugmaker’s IPO until September, Bloomberg News reported this week. German regional lender Oldenburgische ...

FRANKFURT (Reuters) -French banking group Credit Mutuel Alliance Federale is buying German lender Oldenburgische Landesbank ...

Recent shifts in global health highlight urgent concerns over funding shortfalls, international relations, and policy changes. MSF raises alarms on malnutrition in Yemen amid funding cuts. India and ...

--Stada's listing plans are still being discussed and subject to change, according to Bloomberg. JPMorgan Chase, Morgan Stanley, Deutsche Bank, and Goldman Sachs are leading the Stada IPO as global ...

A return to the stock exchange however remains the preference, one of the people said. Stada could be valued at around 10 to ...